Repository

• Home
• Repository
• Publications

Publications

Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinoma Xia C, Krawczyk M, Di C, Krupa Ł, Kruk B, Krawczyk P, Milkiewicz P, Bao H, He X, Liu D, Fan C, Nasser A, Lopens S, Ulrich Weiss F, Frost F, Schierack P, Roggenbuck D, Liu Y. Dig Liver Dis . 2025 Jan;57(1):14-22. doi: 10.1016/j.dld.2024.05.027 2025  Result from

Strategies to enhance the response of liver cancer to pharmacological treatments Marin JJG, Macias RIR, Asensio M, Romero MR, Temprano AG, Pereira OR, Jimenez S, Mauriz JL, Di Giacomo S, Avila MA, Efferth T, Briz O. Am J Physiol Cell Physiol . 2024 Jul 1;327(1):C11-C33. doi: 10.1152/ajpcell.00176.2024 2024  Result from

Insights for clinical management from the real-life data of the centralized West of Scotland biliary cancer clinic Zanuso V, Nash T, Casolino R, Armstrong G, Pallise O, Milne J, Braconi C. BMC Cancer . 2024 May 16;24(1):597. doi: 10.1186/s12885-024-12279-6 2024  Result from

The ABCG8 polymorphism increases the risk of gallbladder cancer in the general population and gallstones in obese patients from Poland. Krupa L, Kalinowski P, Ligocka J, Dauer M, Jankowski K, Gozdowska J, Kruk B, Milkiewicz P, Zieniewicz K, Krawczyk M, Weber SN, Lammert F, Krawczyk M. Eur J Clin Invest . 2024 Aug;54(8):e14213. doi: 10.1111/eci.14213 2024  Result from

The morphomolecular features of cholangiocarcinoma in the personalised era. Field D, Carpino G, Doukas M, Kendall TJ. Diagnostic Histopathology . 2024 Apr 4;30(4). doi: 10.1016/j.mpdhp.2024.01.004. 2024  Result from